Greg Lucier, William Rastetter, Richard Lingard, John DelliSanti | GenomeWeb
BIOCOM, a Southern California life sciences trade association, said this week that it has named eight new members to its board of directors. Invitrogen Chairman and CEO Greg Lucier is chairman of the board for 2007-2008.
 
Among the other board members is William Rastetter, who is a venture partner for Venrock Associates, a former chairman of BIOCOM, and currently serves as chairman of the board of Illumina.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.